Expiratory Molecular Diagnosis Company Sunvou Received Millions of Dollars From Bio Venture
In recent days, expiratory molecular diagnosis company Sunvou just received millions of dollars of funding from Bio Venture. Sunvou is a technology company that engaged in the research, development, production and sales of breathable molecular diagnostic equipment.
Expiratory molecular diagnostics relies on the direct detection of gas molecules in human exhalation to determine the diagnosis of the patient, and is suitable for the diagnosis of various respiratory system diseases and gastrointestinal tract diseases. On the other hand, expiratory molecular diagnostics is also fast, safe, accurate and painless.
Sunvou founder Dr. Jie Han has been engaged in the development of biomedical sensor molecular diagnostic technology in the United States for a long time. He has won 10 awards including the 1997 International Feynman Nanotechnology Award and the 2000 NASA Technology Innovation Leadership Award. He has published more than 100 papers and participated in 4 books about Nano biomedical.
About Bio Venture
Bio Venture is a Chinese venture capital firm that offers early and growth stage investment services.